Powered by Google-Search & Google-Books Chinese Standards Shop Database: 169760 (Oct 17, 2020)
HOME   Quotation   Tax   Examples Standard-List   Contact-Us   View-Cart

YY/T 1249-2014

Chinese Standard: 'YY/T 1249-2014'
Standard IDContents [version]USDSTEP2[PDF] delivered inStandard Title (Description)StatusRelated Standard
YY/T 1249-2014English150 Add to Cart 0--10 minutes. Auto immediate delivery. Free prostate specific antigen quantitative labelling immunoassay kit Valid YY/T 1249-2014
YY/T 1249-2014Chinese14 Add to Cart <=1-day [PDF from Chinese Authority, or Standard Committee, or Publishing House]

  In 0~10 minutes time, full copy of this English-PDF will be auto-immediately delivered to your email. See samples for translation quality.  

Standard ID YY/T 1249-2014 (YY/T1249-2014)
Description (Translated English) Free prostate specific antigen quantitative labelling immunoassay kit
Sector / Industry Medical Device & Pharmaceutical Industry Standard (Recommended)
Classification of Chinese Standard C44
Classification of International Standard 11.100
Word Count Estimation 9,975
Date of Issue 2014/6/17
Date of Implementation 2015/7/1
Quoted Standard GB/T 191
Drafting Organization Chinese Institute of Food and Drug test
Administrative Organization National medical clinical testing laboratory and in vitro diagnostic systems Standardization Technical Committee
Regulation (derived from) China Food and Drug Administration in 2014 Bulletin No. 30
Proposing organization State Food and Drug Administration
Issuing agency(ies) State Food and Drug Administration
Summary This Standard applies to the principles of the quantitative determination of free prostate-specific antigen (fPSA) kit (hereinafter referred to as: fPSA kit) for a double antibody sandwich assay. Including enzyme-labeled, (e) a chemiluminescent label, (ti

YY/T 1249‐2014 
ICS 11.100
C 44
Free prostate specific antigen quantitative
labelling immunoassay kit
ISSUED ON. JUNE 17, 2014
Issued by. State Food and Drug Administration
Table of Contents
1  Scope ... 4 
2  Normative references ... 4 
3  Classification ... 4 
4  Requirements ... 5 
5  Test methods ... 7 
6  Marks, labels and instructions ... 8 
7  Packaging, transportation and storage ... 10 
Bibliography ... 11 
This Standard is drafted according to the rules specified in GB/T 1.1-2009.
Please note that some contents of this Document may involve patents. The issuing
authority of this Document does not undertake the responsibility of identifying these
This Standard was proposed by China Food and Drug Administration.
This Standard shall be under the jurisdiction of National Technical Committee (SAC/TC
136) on System of Medical Clinical Test Lab and in Vitro Diagnostic System of
Standardization Administration of China.
Drafting organization of this Standard. National Institutes for Food and Drug Control.
The main drafters of this Standard. Huang Ying, Zhang Chuntao, Shen Shu, Yu Ting, and
Gao Shangxian.
Free prostate specific antigen quantitative labelling
immunoassay kit
1  Scope 
This standard specifies the classification, requirements, test method, marks, labels,
instructions, packaging, transportation, and storage of the free prostate specific antigen
quantitative labelling immunoassay kit.
This standard is applicable to the kit which quantitatively determines the free prostate
specific antigen (fPSA) by the principle of double antibody sandwich method (hereinafter
referred to as. fPSA kit). It includes the immunoassay kit of quantitative determination of
fPSA by using labelling methods such as enzyme labelling, (electrical) chemiluminescent
labelling, (time resolution) fluorescence labelling AS the capture antibody; and using
carriers such as microplates, pipes, magnetic particles, microbeads, and plastic beads AS
the coated antibody.
This standard does not apply to.
a) Reagent which is used to qualitatively or semi-quantitatively determine fPSA by
colloidal gold or other methods (such as. test paper strip, etc.);
b) Various types of fPSA radio-immunity or IRMA kit labelled with 125I and other
radioactive isotopes.
2  Normative references 
The articles contained in the following documents have become part of this Document
when they are quoted herein. For the dated documents so quoted, all the modifications
(Including all corrections) or revisions made thereafter shall be applicable to this
GB/T 191 Packaging - Pictorial marking for handling of goods
3  Classification 
According to different labelling method, fPSA kit can be divided into enzyme labelling fPSA
kit, (electric) chemiluminescence labelling fPSA kit, (time-resolved) fluorescence labelling
5  Test methods 
5.1 Appearance and physical examination
The visual inspection under the natural light shall be in compliance with the provisions of
4.1. The redissolving time of freeze-dried products is measured with timer.
5.2 Linearity
Dose - response curve linearity of the kit’s calibrator shall be in compliance with the
provisions of 4.4. For those kits not equipped with calibrator, USE fPSA national (or
international) standard materials (or other high concentration sample); PREPARE the
proper concentration points (generally no less than 5 points), according to the linear range
specified by the kit instructions. Establish a corresponding dose-response curve. The
linearity shall comply with provisions of 4.2.
5.3 Minimum detection limit
Repeatedly TEST zero-calibrator (or diluent of sample) for not less than 10 times.
Calculate the average value (x ) and standard deviation (SD) of reaction volume (A or
RLU or CPS, etc.). SUBSTITUTE the reaction volume of (x + 2SD) into dose-response
curve. Calculate the corresponding concentration value. It shall comply with provisions of
5.4 Accuracy
fPSA national (or international) standard materials shall be prepared to (generally not less
than 5 points) the concentration points corresponding with the calibrator in the kit, by using
the kit buffer system. Each point shall be determined for not less than 2 times in parallel.
CCALCULATE the slope rate and potency ratio of 2 dose-response curves. It shall comply
with provisions of 4.4.
For the kit that has not been equipped with a series of calibrators, within the measurement
range specified by the kit, SELECT an appropriate buffer system; USE national (or
international) standard materials of free prostate specific antigen to prepare 2 - 3
concentration points. Each point shall be determined for not less than 2 times in parallel.
The ratio of the average of determined values AND the theoretical value shall comply with
provisions of 4.4.
5.5 Precision
5.5.1 Within-analysis precision
2 ~ 3 control materials are set up in different areas of dose-response curves. Within a
same-analysis, repeatedly measure each control materials for not be less than 8 times.
The coefficient of variation (CV) of the measured results shall comply with provisions of
It shall contain at least the following contents.
a) Product name and specifications;
b) Name, address, contact information of manufacturing enterprise or after-sales
service organization;
c) Medical Device Registration Certificate Number;
d) Product standard number;
e) Product batch number;
f) Period of validity;
g) Storage conditions.
6.2 Marks and labels of each component package of kit
It shall contain at least the following contents.
a) Product name and specification;
b) Name or trademark of manufacturing enterprise;
c) Product batch number;
d) Period of validity;
e) Storage conditions.
6.3 Instructions of reagent (kit)
It shall generally contain the following contents.
a) Product name;
b) Packaging specifications;
c) Intended use;
d) Inspection principle;
e) Main compositions;
f) Storage conditions and period of validity;
g) Applicable instrument;
h) Sample requirements;
[1] GB/T 3358.1-2009 Statistical Terminology. P......
Related standard:   YY/T 1252-2015  YY/T 1253-2015
Related PDF sample:   YY/T 1240-2014  YY/T 1244-2014
Privacy   ···   Product Quality   ···   About Us   ···   Refund Policy   ···   Fair Trading   ···   Quick Response
Field Test Asia Limited | Taxed in Singapore: 201302277C | Copyright 2012-2020